Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2055296

Cover Image

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2055296

Blood Testing Market, By Test Type, By Technology, By Product, By Application, By End User, By Sample Type, By Geography

PUBLISHED:
PAGES: 165 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4500
PDF & Excel (Multi User License - Up to 7 Users)
USD 7000
PDF & Excel (Corporate User License)
USD 10000

Add to Cart

Blood Testing Market is estimated to be valued at USD 115.76 Bn in 2026 and is expected to reach USD 212.97 Bn by 2033, growing at a compound annual growth rate (CAGR) of 9.1% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 115.76 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 9.10% 2033 Value Projection: USD 212.97 Bn

The global blood testing market represents a critical segment of the healthcare diagnostics industry, encompassing a comprehensive range of laboratory tests and diagnostic procedures that analyze blood samples to detect diseases, monitor health conditions, and guide treatment decisions. Blood testing serves as a fundamental diagnostic tool across various medical specialties, including cardiology, oncology, infectious diseases, diabetes management, and routine health screenings. The market encompasses diverse testing methodologies ranging from traditional laboratory-based assays to innovative point-of-care testing devices, molecular diagnostics, and automated high-throughput systems.

With the increasing prevalence of chronic diseases such as diabetes, cardiovascular disorders, and cancer, coupled with the growing emphasis on preventive healthcare and early disease detection, the demand for blood testing services continues to expand globally. The market is characterized by rapid technological advancements, including the development of minimally invasive testing procedures, enhanced accuracy through artificial intelligence integration, and the emergence of personalized medicine approaches. Key market participants include clinical laboratories, hospitals, diagnostic centers, and point-of-care testing device manufacturers, all contributing to the market's robust growth trajectory driven by aging populations, healthcare infrastructure development, and increased healthcare awareness worldwide.

Market Dynamics

The global blood testing market is propelled by several compelling drivers that fuel its sustained growth trajectory. The primary driver stems from the escalating prevalence of chronic diseases worldwide, including diabetes, cardiovascular disorders, cancer, and infectious diseases, necessitating regular blood monitoring and diagnostic testing for effective disease management and treatment optimization. The aging global population significantly contributes to market expansion as elderly individuals require frequent health screenings and monitoring, driving demand for comprehensive blood testing services. Technological advancements represent another crucial driver, with innovations in point-of-care testing devices, automated laboratory systems, molecular diagnostics, and AI-powered diagnostic tools enhancing testing accuracy, reducing turnaround times, and improving patient outcomes.

The growing emphasis on preventive healthcare and early disease detection further accelerates market growth, as healthcare systems worldwide prioritize proactive health management strategies. However, the market faces notable restraints including high costs associated with advanced diagnostic equipment and testing procedures, which can limit accessibility, particularly in developing regions with constrained healthcare budgets. Stringent regulatory requirements and lengthy approval processes for new diagnostic tests and devices pose additional challenges, potentially delaying market entry and increasing development costs. The shortage of skilled laboratory professionals and technicians in certain regions creates operational constraints for healthcare facilities.

Nevertheless, significant opportunities emerge from the expanding applications of blood testing in personalized medicine, pharmacogenomics, and companion diagnostics, enabling tailored treatment approaches. The growing adoption of home-based and self-testing solutions presents lucrative opportunities, particularly accelerated by the COVID-19 pandemic's impact on healthcare delivery models. Emerging markets in Asia Pacific, Latin America, and Africa offer substantial growth potential driven by improving healthcare infrastructure, increasing healthcare expenditure, and rising awareness about the importance of regular health screenings and diagnostic testing.

Key Features of the Study

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global blood testing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Abbott Laboratories, F. Hoffmann-La Roche Ltd, Siemens Healthineers, Thermo Fisher Scientific Inc., Beckman Coulter Inc. (Danaher Corporation), Bio-Rad Laboratories Inc., Becton Dickinson and Company (BD), Ortho Clinical Diagnostics, Quest Diagnostics Incorporated, PerkinElmer Inc., Grifols S.A., bioMerieux SA, Cepheid (Danaher Corporation), DiaSorin S.p.A., and Nova Biomedical
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global blood testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global blood testing market

Market Segmentation

  • Test Type Insights (Revenue, USD Bn, 2021 - 2033)
  • Clinical Chemistry
    • Basic/Lipid Metabolic Panels
    • Electrolyte Panel
    • Liver Function Tests
    • Renal Function Tests
    • Thyroid Function Tests
    • Blood Glucose Tests
  • Hematology and Coagulation
    • Complete Blood Count (CBC)
    • Platelet Count and Function Tests
    • Prothrombin Time/International Normalized Ratio
    • Activated Partial Thromboplastin Time (aPTT)
  • Immunoassay and Serology
    • Autoimmune Disease Testing
    • Allergy Testing
    • Cancer Biomarker Tests
    • Hormone Level Testing
  • Molecular Blood Tests
    • Nucleic Acid Testing (NAT) for Infectious Diseases
    • Pharmacogenomics
    • Oncology (Liquid Biopsy)
  • Microbiology
  • Blood Culture Tests
  • Gram Stains
  • Others
  • Technology Insights (Revenue, USD Bn, 2021 - 2033)
  • Immunoassay
  • Polymerase Chain Reaction (PCR)
  • Next-Generation Sequencing (NGS)
  • Microarray
  • Clinical Chemistry Analysis
  • Hematology Analyzers
  • Mass Spectrometry
  • Flow Cytometry
  • Product Insights (Revenue, USD Bn, 2021 - 2033)
  • Reagents and Kits
  • Instruments and Analyzers
  • Consumables (tubes, slides, etc.)
  • Software and Services
  • Application Insights (Revenue, USD Bn, 2021 - 2033)
  • Disease Diagnosis
  • Wellness and Health Monitoring
  • Therapeutic Drug Monitoring
  • Pre-Natal Screening
  • Pre-Operative Testing
  • Drug of Abuse Testing
  • End User Insights (Revenue, USD Bn, 2021 - 2033)
  • Hospitals
  • Diagnostic Laboratories
  • Blood Banks
  • Research Institutes and Academia
  • Home Care and Self-Testing Users
  • Sample Type Insights (Revenue, USD Bn, 2021 - 2033)
  • Whole Blood
  • Serum
  • Plasma
  • Regional Insights (Revenue, USD Bn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
  • Abbott Laboratories
  • Hoffmann-La Roche Ltd
  • Siemens Healthineers
  • Thermo Fisher Scientific Inc.
  • Beckman Coulter Inc. (Danaher Corporation)
  • Bio-Rad Laboratories Inc.
  • Becton Dickinson and Company (BD)
  • Ortho Clinical Diagnostics
  • Quest Diagnostics Incorporated
  • PerkinElmer Inc.
  • Grifols S.A.
  • bioMerieux SA
  • Cepheid (Danaher Corporation)
  • DiaSorin S.p.A.
  • Nova Biomedical
Product Code: CMI8688

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Blood Testing Market, By Test Type
    • Global Blood Testing Market, By Technology
    • Global Blood Testing Market, By Product
    • Global Blood Testing Market, By Application
    • Global Blood Testing Market, By End User
    • Global Blood Testing Market, By Sample Type
    • Global Blood Testing Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Driver
  • Restraint
  • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Global Blood Testing Market, By Test Type, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Clinical Chemistry
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
      • Basic/Lipid Metabolic Panels
      • Electrolyte Panel
      • Liver Function Tests
      • Renal Function Tests
      • Thyroid Function Tests
      • Blood Glucose Tests
  • Hematology and Coagulation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
      • Complete Blood Count (CBC)
      • Platelet Count and Function Tests
      • Prothrombin Time/International Normalized Ratio
      • Activated Partial Thromboplastin Time (aPTT)
  • Immunoassay and Serology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
      • Autoimmune Disease Testing
      • Allergy Testing
      • Cancer Biomarker Tests
      • Hormone Level Testing
  • Molecular Blood Tests
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
      • Nucleic Acid Testing (NAT) for Infectious Diseases
      • Pharmacogenomics
      • Oncology (Liquid Biopsy)
  • Microbiology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
      • Blood Culture Tests
      • Gram Stains
      • Others

5. Global Blood Testing Market, By Technology, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Immunoassay
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Polymerase Chain Reaction (PCR)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Next-Generation Sequencing (NGS)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Microarray
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Clinical Chemistry Analysis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Hematology Analyzers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Mass Spectrometry
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Flow Cytometry
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

6. Global Blood Testing Market, By Product, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Reagents and Kits
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Instruments and Analyzers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Consumables (tubes, slides, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Software and Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

7. Global Blood Testing Market, By Application, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Disease Diagnosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Wellness and Health Monitoring
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Therapeutic Drug Monitoring
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Pre-Natal Screening
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Pre-Operative Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Drug of Abuse Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

8. Global Blood Testing Market, By End User, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Diagnostic Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Blood Banks
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Research Institutes and Academia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Home Care and Self-Testing Users
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

9. Global Blood Testing Market, By Sample Type, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Whole Blood
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Serum
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Plasma
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

10. Global Blood Testing Market, By Region, 2021 - 2033, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Product, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Product, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Product, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Product, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Product, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Product, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

11. Competitive Landscape

  • Abbott Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Hoffmann-La Roche Ltd
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Siemens Healthineers
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Thermo Fisher Scientific Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Beckman Coulter Inc. (Danaher Corporation)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bio-Rad Laboratories Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Becton Dickinson and Company (BD)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Ortho Clinical Diagnostics
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Quest Diagnostics Incorporated
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • PerkinElmer Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Grifols S.A.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • bioMerieux SA
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Cepheid (Danaher Corporation)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • DiaSorin S.p.A.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Nova Biomedical
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

12. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

13. References and Research Methodology

  • References
  • Research Methodology
  • About Us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!